Judge Blocks Trump HIV Grant Rules Targeting Transgender Patients
A federal judge in Boston struck down Trump administration conditions that barred federally funded HIV providers from acknowledging transgender patients' gender identity or offering gender-affirming care. Judge William Young ruled the restrictions violate the First and Fifth Amendments, calling them rooted in "animus, loathing, and discrimination."
- Original source: theguardian.com.
- The source published it on Nov 19, 2026 at 8:02 PM.
- No second outlet has reported it yet. Treat it as a single-source claim.
US district judge William Young ruled Thursday that the Trump administration cannot attach restrictions to federal HIV-treatment grants that stop providers from recognizing their transgender patients' gender identity or giving them gender-affirming care. The 165-page decision in Boston followed a non-jury trial in September. Young wrote that the conditions were built on animus: they are based in animus, loathing, and discrimination, he said, adding that they do not stand for justice and defy it.
The conditions were imposed starting in March by the Health Resources and Services Administration, the HHS division that runs the Ryan White HIV/AIDS Program. That program was created by Congress in 1990 to fund medical care for low-income and uninsured people living with HIV. Under the new terms, providers had to ensure funding supported activities using sex-based definitions grounded in biological reality, and not social or medical experimentation, according to the lawsuit. The conditions were meant to implement Trump's executive order directing the government to recognize only two sexes, male and female.
Young, appointed by Republican president Ronald Reagan, found the restrictions violated the First Amendment by penalizing doctors for acknowledging that transgender people exist and for using patients' preferred pronouns. He also said they amounted to unconstitutional sex discrimination under the Fifth Amendment. The plaintiffs, a group of national HIV medical associations and healthcare providers including the American Academy of HIV Medicine, argued the policy clashed with the Ryan White program's statutory mandate to deliver comprehensive medical services to HIV patients, which historically included hormone therapy for transgender people.
Neither HHS nor lawyers for the plaintiffs immediately responded to requests for comment. The administration has also moved to restrict gender-affirming care for transgender inmates in federal prisons, and has backed state laws banning transgender athletes from female sports teams at public schools and universities.
TopicsWilliam Young · Trump administration · US Department of Health and Human Services · Ryan White HIV/AIDS Program · Health Resources and Services Administration · American Academy of HIV Medicine · Donald Trump
Source: theguardian.com
Written by AI from verified reporting.

